GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Purchase Of Business

Beacon Pharmaceuticals (DHA:BEACONPHAR) Purchase Of Business : BDT0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Purchase Of Business?

Beacon Pharmaceuticals's purchase of business for the three months ended in Dec. 2023 was BDT0 Mil. It means Beacon Pharmaceuticals spent BDT0 Mil on purchasing business. Beacon Pharmaceuticals's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was BDT0 Mil.

Compared with last quarter (BDT0 Mil in Sep. 2023 ), Beacon Pharmaceuticals spent the same money on purchasing business in Dec. 2023 (BDT0 Mil).


Beacon Pharmaceuticals Purchase Of Business Historical Data

The historical data trend for Beacon Pharmaceuticals's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Purchase Of Business Chart

Beacon Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Purchase Of Business
Get a 7-Day Free Trial - - - - -

Beacon Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Beacon Pharmaceuticals Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beacon Pharmaceuticals Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Beacon Pharmaceuticals (DHA:BEACONPHAR) Business Description

Traded in Other Exchanges
N/A
Address
9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223
Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals (DHA:BEACONPHAR) Headlines

No Headlines